Search
for
Sort by
Research 151–180 of 536
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Vitamin D and the skin: Focus on a complex relationship: A review
- Traditional and Integrative Approaches to the Treatment of Alopecia
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Differential impact of environmental factors on systemic and localized autoimmunity
- CD27 and IL-35 as diagnostic biomarkers in alopecia areata: First evidence of association with pathogenic scalp bacterial infections
- Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Dental Rehabilitation of a Child Diagnosed With Alopecia Areata Totalis: A Case Report
- The Use of 308-nm Excimer Laser Therapy in Alopecia Areata and Primary Cicatricial Alopecia: A Systematic Review
- Assessment of vitamin D levels in patients with alopecia areata: a case-control study in a Tertiary Care Hospital in North India
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity
- Selective Expression of Chemokine Monokine Induced by Interferon-γ in Alopecia Areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Vaccines, adjuvants and autoimmunity
- Immune therapies for alopecia areata: evidence and new perspectives
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Dietary Habits in Japanese Patients with Alopecia Areata
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- The influence of interferon on healthy and diseased skin
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Immunology of alopecia areata
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy